The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls
Abstract
Parkinson's disease is a common neurodegenerative disorder primarily characterized by rigidity, tremor and bradykinesia. Cognitive impairment and neuropsychiatric symptoms are frequent in Parkinson's disease, with a 70% cumulative incidence of dementia. The aim of this cross-sectional study was to establish the pattern of cerebral atrophy on MRI in Parkinson's disease patients with dementia. We used voxel-based morphometry (VBM) to provide an unbiased means of investigating brain volume loss. Whole brain structural T1-weighted MRI scans from Parkinson's disease patients with dementia (PDD, n = 26), Parkinson's disease patients without dementia (n = 31), Alzheimer's disease patients (n = 28), patients with dementia with Lewy bodies (DLB, n = 17) and control subjects (n = 36) were acquired. Images were analysed using SPM99 and the optimized method of VBM. Reduced grey matter volume in PDD patients compared with controls was observed bilaterally in the temporal lobe, including the hippocampus and parahippocampal gyrus, and in the occipital lobe, the right frontal lobe and the left parietal lobe, as well as some subcortical regions. Parkinson's disease patients without dementia showed reduced grey matter volume in the frontal lobe compared with control subjects. There was significant grey matter atrophy bilaterally in the occipital lobe of PDD patients compared with Parkinson's disease patients. In addition, significant temporal lobe atrophy, including the hippocampus and parahippocampal gyrus was detected in Alzheimer's disease relative to PDD. No significant volumetric differences were observed in PDD compared with DLB. Thus, Parkinson's disease involves grey matter loss in frontal areas. In PDD, this extends to temporal, occipital and subcortical areas, with occipital atrophy in PDD being the only difference between the two groups. This provides important information about the pattern of cerebral atrophy in Parkinson's disease and PDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 3×
“, 1984), the consensus criteria for DLB and PDD (McKeith et al., 1996) and the UK Parkinson's Disease Society Brain Bank criteria for Parkinson's disease (Gibb and Lees, 1988).”
BackgroundInfluentialThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Automated Talairach Atlas labels for functional brain mapping
Lancaster, J. L., Woldorff, M. G., Parsons, L. M., Liotti, M., Freitas, C. S., Rainey, L., Kochunov, P. V., Nickerson, D., Mikiten, S. A., & Fox, P. T. (2000) · Human Brain Mapping · doi:10.1002/1097-0193(200007)10:3<120::aid-hbm30>3.0.co;2-8 · Cited by 3,387
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Cited by
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Svenningsson, P., Westman, E., Ballard, C., & Aarsland, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70152-7 · Cited by 499
Support vector machine-based classification of Alzheimer’s disease from whole-brain anatomical MRI
Magnin, B., Mesrob, L., Kinkingnéhun, S., Pélégrini-Issac, M., Colliot, O., Sarazin, M., Dubois, B., Lehéricy, S., & Benali, H. (2009) · Neuroradiology · doi:10.1007/s00234-008-0463-x · Cited by 470
Parkinson’s disease dementia: a neural networks perspective
Gratwicke, J., Jahanshahi, M., & Foltynie, T. (2015) · Brain · doi:10.1093/brain/awv104 · Cited by 435
Parkinson's disease: The quintessential neuropsychiatric disorder
Weintraub, D., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 423
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
Péran, P., Cherubini, A., Assogna, F., Piras, F., Quattrocchi, C., Peppe, A., Celsis, P., Rascol, O., Démonet, J.-F., Stefani, A., et al. (2010) · Brain · doi:10.1093/brain/awq212 · Cited by 399
“Several studies have measured grey matter density alterations in Parkinson’s disease using this method (Burton et al., 2004; Nagano-Saito et al., 2005; Summerfield et al., 2005; Feldmann et al., 2008; Benninger et al., 2009; Ibarretxe-Bilbao et al., 2009; Wattendorf et al., 2009).”
BackgroundMethodFocal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease
Whitwell, J. L., Weigand, S. D., Shiung, M. M., Boeve, B. F., Ferman, T. J., Smith, G. E., Knopman, D. S., Petersen, R. C., Benarroch, E. E., Josephs, K. A., et al. (2007) · Brain · doi:10.1093/brain/awl388 · Cited by 349
Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease
Pagonabarraga, J., Kulisevsky, J., Llebaria, G., García‐Sánchez, C., Pascual‐Sedano, B., & Gironell, A. (2008) · Movement Disorders · doi:10.1002/mds.22007 · Cited by 344
Personality, Addiction, Dopamine: Insights from Parkinson's Disease
Dagher, A., & Robbins, T. W. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.031 · Cited by 340
Regional Grey Matter Changes in Patients With Migraine: A Voxel-Based Morphometry Study
Kim, J., Suh, S.-I., Seol, H., Oh, K., Seo, W.-K., Yu, S.-W., Park, K.-W., & Koh, S.-B. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01550.x · Cited by 324
Morris, R., Lord, S., Bunce, J., Burn, D., & Rochester, L. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.012 · Cited by 307
EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia
Sorbi, S., Hort, J., Erkinjuntti, T., Fladby, T., Gainotti, G., Gurvit, H., Nacmias, B., Pasquier, F., Popescu, B. O., Rektorova, I., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03784.x · Cited by 306
Cerebral atrophy and its relation to cognitive impairment in Parkinson disease
Nagano-Saito, A., Washimi, Y., Arahata, Y., Kachi, T., Lerch, J. P., Evans, A. C., Dagher, A., & Ito, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149510.41793.50 · Cited by 284
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia
Vendette, M., Gagnon, J. F., Décary, A., Massicotte-Marquez, J., Postuma, R. B., Doyon, J., Panisset, M., & Montplaisir, J. (2007) · Neurology · doi:10.1212/01.wnl.0000278114.14096.74 · Cited by 283
Magnetic resonance imaging for the diagnosis of Parkinson’s disease
Heim, B., Krismer, F., De Marzi, R., & Seppi, K. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1717-8 · Cited by 272
“2015) investigated volume changes in patients with PD compared to controls using a plethora of studies (Burton et al. 2004; Cordato et al. 2005; Nagano-Saito et al. 2005; Summerfield et al. 2005; Beyer et al. 2007; Ramirez-Ruiz et al. 2007; Karagulle Kendi et al. 2008; Camicioli et al. 2009; Jubault et al. 2009; Marti…”
MethodResultPrevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Jellinger, K. A., & Attems, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0347-5 · Cited by 268
Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K., Brooks, D. J., et al. (2015) · Brain · doi:10.1093/brain/awv211 · Cited by 260
Cognitive impairment and dementia in Parkinson's disease
Pagonabarraga, J., & Kulisevsky, J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.029 · Cited by 257
Zadikoff, C., & Lang, A. E. (2005) · Brain · doi:10.1093/brain/awh560 · Cited by 257
Beyer, M. K., Janvin, C. C., Larsen, J. P., & Aarsland, D. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.093849 · Cited by 255
Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease
Bohnen, N. I., Albm, R. L., Koeppe, R. A., Wernette, K. A., Kilbourn, M. R., Minoshima, S., & Frey, K. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600276 · Cited by 254
Tam, C. W. C., Burton, E. J., McKeith, I. G., Burn, D. J., & O’Brien, J. T. (2005) · Neurology · doi:10.1212/01.wnl.0000153070.82309.d4 · Cited by 209
Self-citationMindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI
Pickut, B. A., Van Hecke, W., Kerckhofs, E., Mariën, P., Vanneste, S., Cras, P., & Parizel, P. M. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.10.002 · Cited by 174
Disentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven Methods
Habes, M., Grothe, M. J., Tunc, B., McMillan, C., Wolk, D. A., & Davatzikos, C. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.016 · Cited by 167
Messina, D., Cerasa, A., Condino, F., Arabia, G., Novellino, F., Nicoletti, G., Salsone, M., Morelli, M., Lanza, P. L., & Quattrone, A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.12.010 · Cited by 163
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies
Nedelska, Z., Ferman, T. J., Boeve, B. F., Przybelski, S. A., Lesnick, T. G., Murray, M. E., Gunter, J. L., Senjem, M. L., Vemuri, P., Smith, G. E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.005 · Cited by 155
Williams-Gray, C. H., Foltynie, T., Lewis, S. J. G., & Barker, R. A. (2006) · CNS Drugs · doi:10.2165/00023210-200620060-00004 · Cited by 147
O'Sullivan, J. B., Ryan, K. M., Curtin, N. M., Harkin, A., & Connor, T. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800967x · Cited by 146
EFNS task force: the use of neuroimaging in the diagnosis of dementia
Filippi, M., Agosta, F., Barkhof, F., Dubois, B., Fox, N. C., Frisoni, G. B., Jack, C. R., Johannsen, P., Miller, B. L., Nestor, P. J., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03859.x · Cited by 141
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Valera, E., & Masliah, E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.013 · Cited by 132
Neuroimaging characteristics of dementia with Lewy bodies
Mak, E., Su, L., Williams, G. B., & O’Brien, J. T. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt248 · Cited by 120
Kamagata, K., Zalesky, A., Hatano, T., Ueda, R., Di Biase, M. A., Okuzumi, A., Shimoji, K., Hori, M., Caeyenberghs, K., Pantelis, C., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23628 · Cited by 106
“On the contrary, there are many reports on the occurrence of widespread atrophy in the frontal, temporal, limbic, and paralimbic areas of the brain [Biundo et al., 2011; Burton et al., 2004; Jubault et al., 2011; Lyoo et al., 2010; Meppelink et al., 2011; Tinaz et al., 2011].”
BackgroundStaffaroni, A., Elahi, F., McDermott, D., Marton, K., Karageorgiou, E., Sacco, S., Paoletti, M., Caverzasi, E., Hess, C., Rosen, H., et al. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608808 · Cited by 91
Neuroimaging in Parkinson’s disease dementia: connecting the dots
Weil, R. S., Hsu, J. K., Darby, R. R., Soussand, L., & Fox, M. D. (2019) · Brain Communications · doi:10.1093/braincomms/fcz006 · Cited by 71
Temporal irreversibility of large-scale brain dynamics in Alzheimer's disease
Cruzat, J., Herzog, R., Prado, P., Sanz-Perl, Y., Gonzalez-Gomez, R., Moguilner, S., Kringelbach, M. L., Deco, G., Tagliazucchi, E., & Ibañez, A. (2023) · The Journal of Neuroscience · doi:10.1523/jneurosci.1312-22.2022 · Cited by 57
Huang, H., Zheng, S., Yang, Z., Wu, Y., Li, Y., Qiu, J., Cheng, Y., Lin, P., Lin, Y., Guan, J., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhac099 · Cited by 57
Dopaminergic system and dream recall: an MRI study in Parkinson's disease patients
De Gennaro, L., Lanteri, O., Piras, F., Scarpelli, S., Assogna, F., Ferrara, M., Caltagirone, C., & Spalletta, G. (2016) · Human Brain Mapping · doi:10.1002/hbm.23095 · Cited by 45
Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia
Burton, E. J., Mukaetova-Ladinska, E. B., Perry, R. H., Jaros, E., Barber, R., & O'Brien, J. T. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.015 · Cited by 43
Self-citationMultimodal mechanisms of human socially reinforced learning across neurodegenerative diseases
Legaz, A., Abrevaya, S., Dottori, M., González Campo, C., Birba, A., Martorell Caro, M., Aguirre, J., Slachevsky, A., Aranguiz, R., Serrano, C., et al. (2022) · Brain · doi:10.1093/brain/awab345 · Cited by 34
Metadata
- Authors
- Burton, E. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-14
- Volume
- 127
- Issue
- 4
- Pages
- 791-800
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2146427423
- Cited by
- 647
- References
- 48
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.